Activities of the human immunodeficiency virus type 1 (HIV-1) protease inhibitor nelfinavir mesylate in combination with reverse transcriptase and protease inhibitors against acute HIV-1 infection in vitro
about
BMS-232632, a highly potent human immunodeficiency virus protease inhibitor that can be used in combination with other available antiretroviral agentsGenotypic and phenotypic characterization of human immunodeficiency virus type 1 variants isolated from patients treated with the protease inhibitor nelfinavir.Emergence of drug resistance mutations in human immunodeficiency virus type 2-infected subjects undergoing antiretroviral therapyIn vitro activities of retigeric acid B alone and in combination with azole antifungal agents against Candida albicansScreening of FDA-Approved Drugs for Inhibitors against Japanese Encephalitis Virus Infection.Protease inhibitors as antiviral agents.Resistance to human immunodeficiency virus type 1 protease inhibitors.In vitro antiviral interaction of lopinavir with other protease inhibitors.In vitro interaction of flucytosine combined with amphotericin B or fluconazole against thirty-five yeast isolates determined by both the fractional inhibitory concentration index and the response surface approach.Comparison of fractional inhibitory concentration index with response surface modeling for characterization of in vitro interaction of antifungals against itraconazole-susceptible and -resistant Aspergillus fumigatus isolatesTMC114, a novel human immunodeficiency virus type 1 protease inhibitor active against protease inhibitor-resistant viruses, including a broad range of clinical isolates.Screening of Potential HIV-1 Inhibitors/Replication Blockers Using Secure Lentiviral in Vitro System.
P2860
Q28344472-888C3983-F11B-40C4-A0E8-CCAEF4BB8281Q28369030-AD309794-FA79-418C-8E6E-B70C159B96C2Q33966329-106B6170-ED9E-4CDE-9DA8-4E0FCACEB4C5Q37144780-02CDC6CA-961D-42C8-8D09-98482A8BD069Q38156719-DFF7690E-D445-46CE-ABFD-B206E14F1F0EQ39468942-D02F26E9-1405-406A-B046-6B695C8CBDD4Q39559316-F4B0F800-B035-48CE-A4B9-D4075BEBBBFFQ39652270-CB544D51-76D7-47F8-AAC1-12D9184EAB79Q39652783-7263786E-9F31-4D79-89D4-06BA294CF824Q39653016-F30D32E2-7EE9-4E41-9ED3-AFFFAC95C19BQ40417023-F941A4E4-F91A-404F-8361-8878E915D3C6Q41961457-2C2B058E-3B54-4668-B220-59DFCCF117A8
P2860
Activities of the human immunodeficiency virus type 1 (HIV-1) protease inhibitor nelfinavir mesylate in combination with reverse transcriptase and protease inhibitors against acute HIV-1 infection in vitro
description
1997 nî lūn-bûn
@nan
1997 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Activities of the human immuno ...... acute HIV-1 infection in vitro
@ast
Activities of the human immuno ...... acute HIV-1 infection in vitro
@en
Activities of the human immuno ...... acute HIV-1 infection in vitro
@nl
type
label
Activities of the human immuno ...... acute HIV-1 infection in vitro
@ast
Activities of the human immuno ...... acute HIV-1 infection in vitro
@en
Activities of the human immuno ...... acute HIV-1 infection in vitro
@nl
prefLabel
Activities of the human immuno ...... acute HIV-1 infection in vitro
@ast
Activities of the human immuno ...... acute HIV-1 infection in vitro
@en
Activities of the human immuno ...... acute HIV-1 infection in vitro
@nl
P2093
P2860
P356
P1476
Activities of the human immuno ...... acute HIV-1 infection in vitro
@en
P2093
P2860
P304
P356
10.1128/AAC.41.10.2159
P407
P577
1997-10-01T00:00:00Z